Nancy U. Lin, MD on Tucatinib vs. Placebo Added to Trastuzumab @DanaFarber

Nancy U. Lin, MD on Tucatinib vs. Placebo Added to Trastuzumab @DanaFarber

User Photo
Cancer-News

2 months
9 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Nancy U. Lin, MD of Dana-Farber Cancer Institute @DanaFarber discusses tucatinib vs. placebo added to trastuzumab and capecitabine for patients with previously treated HER2+ metastatic breast cancer with brain metastases

Read here: https://meetinglibrary.asco.org/record/185141/abstract

Up Next Autoplay